Conference Coverage
Conference Coverage
Study reveals barriers to accessing palliative care services
©ASCO/Todd Buchanan 2016 SAN FRANCISCO—Patients may face challenges when trying to access palliative and supportive care services at cancer...
Conference Coverage
Cancer patients’ caregivers may carry greater burden
©ASCO/Todd Buchanan 2016 SAN FRANCISCO—New research suggests caring for a loved one with cancer may be more burdensome than caring for a loved...
Conference Coverage
Improving communication between cancer pts and docs
©ASCO/Todd Buchanan 2016 SAN FRANCISCO—Results of the VOICE study showed that training advanced cancer patients and their oncologists on how to...
Conference Coverage
Data are mixed on cancerous transformation of cardiac mucosa in Barrett’s esophagus
CHICAGO – The risk arising from this nonintestinal metaplasia growth is probably quite low in real life, but the extant literature gives doctors...
Conference Coverage
Longer DAPT better for PAD, study suggests
Photo by Sage Ross ROME—A subanalysis of the PRODIGY study suggests a longer duration of dual antiplatelet therapy (DAPT) improves outcomes after...
Conference Coverage
Edoxaban appears comparable to standard therapy
ROME—The novel oral anticoagulant edoxaban is a feasible treatment option for patients with atrial fibrillation (AF) who need anticoagulation...
Conference Coverage
Simple algorithm can rule out PE, team says
Image courtesy of Medical College of Georgia ROME—A new study suggests the YEARS algorithm may provide a simple method for ruling out pulmonary...
Conference Coverage
Antiplatelet drugs comparable in patients with AMI
Photo courtesy of AstraZeneca ROME—The antiplatelet drugs prasugrel and ticagrelor produce similar early results in patients with acute...
Conference Coverage
Antidote to factor Xa inhibitors exhibits efficacy in patients with major bleeding
ROME—Preliminary results from the ANNEXA-4 study suggest that andexanet alfa, an investigational antidote to factor Xa inhibitors, can be...
Conference Coverage
Antiplatelet monitoring doesn’t benefit high-risk patient group
Photo courtesy of NIH ROME—Results of the ANTARCTIC trial suggest that monitoring platelet function to individualize antiplatelet therapy does...
Conference Coverage
Rule identifies women at low risk of VTE recurrence
of women in a family ROME—According to researchers, a clinical decision rule can identify women who, after their first unprovoked venous...